Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
Debashree Chatterjee, Alexandra Tauzin, Lorie Marchitto, et al.
Cell Reports (2022) Vol. 38, Iss. 9, pp. 110429-110429
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 471
Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission
Bradley Pickering, Oliver Lung, Finlay Maguire, et al.
Nature Microbiology (2022) Vol. 7, Iss. 12, pp. 2011-2024
Open Access | Times Cited: 181
Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
Rishi R. Goel, Mark M. Painter, Kendall A. Lundgreen, et al.
Cell (2022) Vol. 185, Iss. 11, pp. 1875-1887.e8
Open Access | Times Cited: 177
Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages
Jingwen Ai, Xun Wang, Xinyi He, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 8, pp. 1077-1083.e4
Open Access | Times Cited: 167
Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 78
Tracking the COVID-19 vaccines: The global landscape
Tushar Yadav, Swatantra Kumar, Gourav Mishra, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 48
Highly divergent white-tailed deer SARS-CoV-2 with potential deer-to-human transmission
Bradley Pickering, Oliver Lung, Finlay Maguire, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 62
Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
Deepta Bhattacharya
Immunity (2022) Vol. 55, Iss. 6, pp. 945-964
Open Access | Times Cited: 47
Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection
Jamie Guenthoer, Michelle M. Lilly, Tyler N. Starr, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 23
Open Access | Times Cited: 27
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
Alexandra Tauzin, Alexandre Nicolas, Shilei Ding, et al.
Cell Reports (2023) Vol. 42, Iss. 1, pp. 111998-111998
Open Access | Times Cited: 22
Prior Vaccination Exceeds Prior Infection in Eliciting Innate and Humoral Immune Responses in Omicron Infected Outpatients
Hye‐Kyung Lee, Ludwig Knabl, Mary Walter, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin
Yuhang Shi, Sydney Simpson, Yuexuan Chen, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 1, pp. e1011912-e1011912
Open Access | Times Cited: 6
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon
Mehdi Benlarbi, Dell-Dylan Kenfack, Katrina Dionne, et al.
Virology (2025) Vol. 605, pp. 110467-110467
Closed Access
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron
Mehdi Benlarbi, Geneviève Laroche, Corby Fink, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105316-105316
Open Access | Times Cited: 25
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
Alexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Cell Reports (2022) Vol. 41, Iss. 4, pp. 111554-111554
Open Access | Times Cited: 22
Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
Shô Miyamoto, Takeshi Arashiro, Akira Ueno, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105969-105969
Open Access | Times Cited: 12
Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development
Shô Miyamoto, Tadaki Suzuki
Vaccine (2024) Vol. 42, Iss. 6, pp. 1401-1406
Closed Access | Times Cited: 4
Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron
Justyna Sieber, Margareta Mayer, Klara Schmidthaler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
Alexandra Tauzin, Gabrielle Gendron‐Lepage, Manon Nayrac, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 532-532
Open Access | Times Cited: 19
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
Manon Nayrac, Mathieu Dubé, Gérémy Sannier, et al.
Cell Reports (2022) Vol. 39, Iss. 13, pp. 111013-111013
Open Access | Times Cited: 19
Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission
Mehdi Benlarbi, Shilei Ding, Étienne Bélanger, et al.
mBio (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 3
The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2
Jamie Guenthoer, Meghan Garrett, Michelle M. Lilly, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012383-e1012383
Open Access | Times Cited: 3
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults
Alina Seidel, Michelle Zanoni, Rüdiger Groß, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells
Alexandre Nicolas, Gérémy Sannier, Mathieu Dubé, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105904-105904
Open Access | Times Cited: 17
A Recent SARS-CoV-2 Infection Enhances Antibody-Dependent Cellular Cytotoxicity against Several Omicron Subvariants following a Fourth mRNA Vaccine Dose
Guillaume Beaudoin-Bussières, Alexandra Tauzin, Katrina Dionne, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1274-1274
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top